#154831

Anti-Proliferation marker [JC1] rAb

Cat. #154831

Anti-Proliferation marker [JC1] rAb

Cat. #: 154831

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Proliferation marker

Class: Recombinant

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Absolute Antibody; University of Oxford

Tool Details
Target Details
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-Proliferation marker [JC1] rAb
  • Clone: JC1
  • Tool sub type: Primary antibody
  • Class: Recombinant
  • Conjugation: Unconjugated
  • Molecular weight: 212 kDa and 123 kDa
  • Reactivity: Human
  • Host: Mouse
  • Description: JC1 detects a nuclear antigen, distinct from Ki67, present in proliferating cells. It is useful as a marker of proliferation in cases such as squamous cell carcinoma where the Ki67 index cannot be determined.
  • Immunogen: Pokeweed-stimulated lymphocytes
  • Isotype: IgG2a

Target Details

  • Target: Proliferation marker
  • Molecular weight: 212 kDa and 123 kDa
  • Target background: JC1 detects a nuclear antigen, distinct from Ki67, present in proliferating cells. It is useful as a marker of proliferation in cases such as squamous cell carcinoma where the Ki67 index cannot be determined.

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Shipping at 4° C

References

  • Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2.
  • EMMPRIN, SP1 and microRNA-27a mediate physcion 8-O-?-glucopyranoside-induced apoptosis in osteosarcoma cells.
  • Garrido et al. 1992. J Clin Pathol. 45(10):860-5. PMID: 1430255.
  • Li et al. 2017. J Exp Clin Cancer Res. 36(1):58. PMID: 28427443.
  • Monoclonal antibody JC1: new reagent for studying cell proliferation.
  • Unexpected Discovery of Dichloroacetate Derived Adenosine Triphosphate Competitors Targeting Pyruvate Dehydrogenase Kinase To Inhibit Cancer Proliferation.
  • Wang et al. 2016. Am J Cancer Res. 6(6):1331-44. PMID: 27429847.
  • Zhang et al. 2016. J Med Chem. 59(7):3562-8. PMID: 27006991.